Monday June 26th 2017

Posts Tagged ‘zamboni’

Knutsford man to travel to Poland for pioneering MS surgery

Knutsford man to travel to Poland for pioneering MS surgery

A MAN who suffers from a paralysing disease is set to travel to Poland for a pioneering treatment which could reverse his condition. Colm McLaughlin, who has multiple sclerosis (MS), will fly to a clinic in Krakow on June 22 for a radical treatment which has divided the [Read More]

Controversial treatment creating bitterness in MS Society elections

Controversial treatment creating bitterness in MS Society elections

The Multiple Sclerosis Society’s national board election next week is expected to become a battleground as members rally to shut out supporters of a controversial treatment. An e-mail circulated on Friday urged MS Society supporters to sign up to become members, which [Read More]

MS patients tell MPs about life after ‘liberation’

MS patients tell MPs about life after ‘liberation’

A group of patients with multiple sclerosis gathered on Parliament Hill Tuesday to testify how a controversial new treatment has changed their lives, as two Liberal MPs reiterated their call for more research. The patients included Steve Garvie and Lianne Webb, both of whom [Read More]

 Page 1 of 5  1  2  3  4  5 »

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]